Trends in Healthcare Finance Innovations

In this edition of Fintech Wrap Up, we dive deep into Healthcare x Fintech—a space that’s ripe for disruption as financial inefficiencies continue to plague the $4 trillion healthcare industry. Our deep dive explores these opportunities through the lens of a16z a venture capital firm that is drawing insights from emerging trends and the evolving fintech landscape. Imagine running a business where you don’t know how much you’ll get paid, when the money will arrive, or whether it’s even the correct amount. That’s the financial reality for most healthcare providers today. Unlike other industries, healthcare lacks a true financial operating system, leaving providers scrambling to track revenue, reconcile payments, and manage cash flow manually. The result? A system rife with inefficiencies, surprise payment gaps, and even insolvency risks. The good news? Fintech is stepping in to fill the gap. From revenue cycle management to AI-powered financial forecasting, the race is on to build the Financial OS for Healthcare—a real-time, action-driven financial backbone that integrates with EHRs, billing systems, and banking tools to give providers better control over their cash flow. And let’s not forget the rise of Consumers as a New Class of Payor. With out-of-pocket healthcare spending reaching $471 billion, fintech startups are reimagining health payments—think BNPL for medical bills, tax-advantaged spending accounts, and even marketplaces for cash-pay procedures. We also break down the Unbundling of Payvidors—the massive insurance-and-care giants like UnitedHealth, Anthem, and Aetna that dominate healthcare finances. While these firms control the ecosystem, fintech upstarts are chipping away at their dominance with modern, user-friendly alternatives in areas like insurance, platform services, and provider payments. The next era of healthcare fintech will be shaped by those who can move fast, integrate financial services directly into care delivery, and build consumer-first payment solutions that make navigating healthcare as seamless as booking a flight. The bottom line? Fintech has the power to bring transparency, predictability, and innovation to healthcare finances—and the companies solving these pain points today are positioned to define the future of healthcare payments. #fintech #payments #healthcare Prasanna Thomas Richard Panagiotis Tony Nicolas Arjun Dr Ritesh Sandra Leda

I’ve spent most of my career driving innovation in healthcare. And the most interesting innovation I’m seeing right now is coming from the Center for Medicare and Medicaid Innovation (CMMI). On their own, most of these models feel incremental. Interesting, but contained. But when you line them up side by side… You start to see something very different. Not pilots. Not experiments. A directional shift in how care is going to be paid for. Across models like ACCESS, MAHA ELEVATE, BALANCE, and the evolving ACO/system models, a pattern shows up: Care is moving from episodic → continuous Payment is moving from claims → outcomes + funding hybrids Delivery is moving from provider-centric → ecosystem (tech + services) Time horizons are stretching from annual resets → 10-year bets This is not random. It’s portfolio design. And it starts to matter when you look at it through the lens of who moves first. If you’re a digital health founder, this may finally be the signal you’ve been waiting for. CMS is beginning to test payment for longitudinal engagement, behavior change, and non-traditional care models. But it also raises the bar. It won’t be enough to have a product—you’ll need to align with partners and payment structures. If you’re a health system executive, it’s tempting to treat these as optional pilots. But if CMS starts funding continuous management, lifestyle intervention, and digitally enabled care outside your walls… you may gain new partners. But those partners may also displace you as the center of gravity of care delivery. If you’re a payer, this is a different kind of signal. CMMI is effectively testing new cost structures in public view— what gets funded, what gets measured, and what actually bends trend. Some of these models may reduce downstream utilization. Others may introduce new categories of spend. Either way, they start to redefine: what is “medical” what is reimbursable and where margin actually lives And if you’re an investor, this is where it gets interesting. CMMI isn’t picking winners. They’re creating parallel payment pathways and letting the market respond. That’s how new categories emerge. Looking at these models individually, you see innovation. Looking at them together, you see market design. As these models take shape, where do you place your next strategic bet—and what’s your timing?

Andy Slavitt and Andie Steinberg from Town Hall Ventures just dropped their take on nine major healthcare shifts coming down the pike, and honestly it got me spinning on what the actual investable opportunities look like for angels and early stage folks. The TLDR is that we’re hitting one of those rare moments where policy changes and tech maturity are converging in ways that create real wedges for startups. MAHA pushing outcomes over activity. MA plans about to get 200 to 400 bps of margin relief. CMMI getting a refresh. GenAI finally ready for primetime in clinical workflows. Dual eligible integration becoming mandatory instead of optional. What makes this interesting is not the macro narrative but the specific gaps these shifts create. When MA plans suddenly have margin room but also face pressure to prove they’re actually improving health outcomes, they need tools they don’t have. When CMMI launches consumer incentive models, someone has to build the infrastructure to operationalize them. When AI adoption gets federal push but health systems have zero internal capability, services businesses emerge. I walked through nine potential business models in the full piece. Prevention infrastructure platforms. Consumer engagement as a service. MA enablement software. Pharmacy transparency tools. CMMI model operators. AI implementation partners. Dual eligible care coordination. ICHRA infrastructure. And some thoughts on reconciliation arbitrage plays. The meta framework is pretty straightforward. Look for problems that are newly urgent not just newly interesting. Find wedges that don’t require customers to bet the company. Build toward defensible moats beyond first mover advantage. And make sure the team actually understands how healthcare works operationally not just theoretically. Not all of these will pan out obviously. Policy could shift weird. Tech could disappoint. Incumbents might adapt faster than expected. But for anyone writing checks into early stage healthcare companies right now, these trends give you a map of where genuine market gaps are likely to emerge and where startups might actually have windows to build something defensible. Worth noting that healthcare transitions always favor new entrants because they introduce complexity incumbents struggle with. The orgs that built their businesses around fee for service aren’t naturally equipped for outcomes and prevention and consumer engagement. That gap is where startups live, at least until they get acquired or the big guys catch up. Wrote this mainly for angels evaluating deals and founders trying to figure out where to focus, but figured it might be useful for anyone trying to make sense of what’s actually changing in healthcare policy and what it means for company building. ----- Disclaimer: These thoughts and opinions are my own and do not reflect the views of my employer or any other entities. ----- Link to the full analysis in the comments below.

𝐁𝐞𝐲𝐨𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐓𝐞𝐜𝐡: 𝐖𝐡𝐲 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞’𝐬 𝐅𝐮𝐭𝐮𝐫𝐞 𝐢𝐬 𝐚 𝐅𝐢𝐧𝐭𝐞𝐜𝐡 𝐏𝐥𝐚𝐲 💳 🩺   The US healthcare industry is an economic contradiction. It’s a $4.9 trillion behemoth consuming nearly 20% of GDP, yet it remains a "digital laggard." Nearly $1 trillion is annually devoured by administrative waste - money that disappears into the friction of claims, billing, and reconciliation without ever touching a patient. But the "slow to change" narrative was shattered in 2025. Menlo Ventures data shows that healthcare is now adopting AI at 2.2x the pace of the broader economy. We are moving from "services dollars" (manual labor in billing) to "software dollars" (autonomous agents). This isn’t just a clinical upgrade; it is a financial re-architecture.   𝐕𝐞𝐫𝐭𝐢𝐜𝐚𝐥 𝐅𝐢𝐧𝐭𝐞𝐜𝐡: 𝐂𝐨𝐧𝐭𝐞𝐱𝐭 𝐚𝐬 𝐚 𝐌𝐨𝐚𝐭 🧠 Horizontal Fintech solutions have reached scale, but the current wave of innovation is about depth. We believe vertical solutions built around the unique DNA of specific industries offer the highest defensibility. In healthcare, this is where clinical data meets financial flow. 5 𝐅𝐨𝐫𝐜𝐞𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 + 𝐅𝐢𝐧𝐭𝐞𝐜𝐡 𝐈𝐧𝐭𝐞𝐫𝐬𝐞𝐜𝐭𝐢𝐨𝐧:   🏥 𝑹𝒆𝒈𝒖𝒍𝒂𝒕𝒐𝒓𝒚 𝑻𝒂𝒊𝒍𝒘𝒊𝒏𝒅𝒔: Interoperability mandates (like FHIR standards) are finally unlocking data silos.   🔖 𝑽𝒂𝒍𝒖𝒆-𝑩𝒂𝒔𝒆𝒅 𝑪𝒂𝒓𝒆: Shifting from "fee-for-service" to "outcomes-based" models requires sophisticated financial engineering old systems can't handle.   🤑 𝑻𝒉𝒆 𝑴𝒂𝒓𝒈𝒊𝒏 𝑺𝒒𝒖𝒆𝒆𝒛𝒆: Providers can no longer afford the 3-4% "leakage" in their revenue cycles due to rising costs and labor shortages.   🤳 𝑪𝒐𝒏𝒔𝒖𝒎𝒆𝒓𝒊𝒛𝒂𝒕𝒊𝒐𝒏: In 2026, patients expect the same seamless payment flows and transparency they get in every other part of their lives.   👩🏻⚕ 𝑻𝒉𝒆 𝑾𝒐𝒓𝒌𝒇𝒐𝒓𝒄𝒆 𝑪𝒓𝒊𝒔𝒊𝒔: Clinical burnout is at an all-time high. Doctors didn’t go to med school to fight insurance portals. Automating the administrative burden is no longer just an efficiency play – it’s a retention play.   𝐓𝐡𝐞 1𝐬𝐭 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐅𝐢𝐧𝐭𝐞𝐜𝐡 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐌𝐚𝐩 📍  To see how these five forces are playing out in real-time, we’ve mapped the ecosystem of companies - from autonomous billing agents to patient platforms that are turning this problem into a massive opportunity. 𝘐𝘧 𝘺𝘰𝘶’𝘳𝘦 𝘸𝘰𝘳𝘬𝘪𝘯𝘨 𝘰𝘯 𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘦𝘹𝘤𝘪𝘵𝘪𝘯𝘨 𝘪𝘯 𝘏𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘍𝘪𝘯𝘵𝘦𝘤𝘩 𝘰𝘳 𝘺𝘰𝘶 𝘵𝘩𝘪𝘯𝘬 𝘺𝘰𝘶𝘳 𝘤𝘰𝘮𝘱𝘢𝘯𝘺 𝘴𝘩𝘰𝘶𝘭𝘥 𝘣𝘦 𝘪𝘯 𝘵𝘩𝘪𝘴 𝘮𝘢𝘱, 𝘭𝘦𝘵 𝘮𝘦 𝘬𝘯𝘰𝘸 💌 Check out the full blog post and startup map here ⬇️ https://shorturl.at/LpuLM (including examples such as ecton Camber Stedi Clearest Health Rialtic Sheer Health PayZen Flychain Nayya) Viola FinTech Daniel Tsiddon Avi Zeevi

Silicon Valley Bank's "𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡𝐭𝐞𝐜𝐡 𝟐𝟎𝟐𝟓" report reveals a fundamental shift in healthcare technology investment, with administrative AI now driving the sector instead of clinical care models. 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 - Healthtech has reached record venture capital share in 2025, with provider operations (scheduling, documentation, billing) attracting $5.5B and representing 44% of all investment—up from just 19% in 2021. - Alternative care models like telehealth have plummeted from 42% to only 9% of investment dollars. AI companies in provider operations have seen their share leap nearly 60% since 2024, with AI-enabled operations capturing 73% of all healthtech mega-deals. 𝐓𝐡𝐫𝐞𝐞 𝐊𝐞𝐲 𝐓𝐡𝐞𝐦𝐞𝐬 - 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐈 𝐃𝐨𝐦𝐢𝐧𝐚𝐧𝐜𝐞: Sector has definitively shifted from clinical to administrative focus, with front- and back-office tools solving business problems rather than medical care issues. AI applications in documentation, revenue cycle management, and workflow automation are freeing provider time for patient care. - 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐌&𝐀 𝐄𝐱𝐢𝐭𝐬: With IPOs largely frozen, consolidation through mergers and acquisitions has become the primary exit path. Strategic investors like UnitedHealth Group, Boston Scientific, and CVS, along with private equity, are building platforms through roll-ups. Recent successful IPOs from Tempus and Hinge Health show strong fundamentals still attract public markets. - 𝐄𝐚𝐫𝐥𝐲-𝐒𝐭𝐚𝐠𝐞 𝐕𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐁𝐮𝐛𝐛𝐥𝐞:   Seed and Series A AI valuations have surpassed 2021 boom levels, creating concerns about investment inflation. While mid- and late-stage valuations also rise, the bubble is most pronounced in early stages. Infrastructure companies and those addressing revenue cycle problems are considered best positioned to survive. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐧𝐭𝐞𝐱𝐭 - US healthcare landscape faces challenges with 27 million uninsured Americans (first increase since 2019), and projections suggest 14 million more could lose coverage in the next decade. Americans increasingly avoid medical care, mental health treatment, and medications to save money. - Despite spending twice the median per capita of other developed countries, US healthcare outcomes remain middle-of-the-pack. 𝐍𝐨𝐭𝐚𝐛𝐥𝐞 𝐓𝐫𝐞𝐧𝐝𝐬 - Ambient documentation has emerged as the hottest investment area, with deals like Abridge's $315M and Truveta's $320M leading 2025. - Nearly half of AI-enabled medical device recalls occurred within the first year of clearance, and hospitals primarily adopt lower-risk tools like scheduling assistants rather than clinical AI. - Eight of the top 10 valued healthtech unicorns haven't raised at higher valuations in over three years, creating an exit backlog. SVB | Jennifer Friel Goldstein | Dennis He | Nina Kandilian | Raysa Bousleiman | Alexander Lennox-Miller | Anjalika Komatireddy

Buy Now, Pay Later (BNPL) has reshaped commerce, but can it reshape healthcare? In our conversation with Dr. Abayomi Olajide, one insight was clear: Access to care isn’t just about availability; it’s about affordability at the moment people need help most. For millions across LMICs, the biggest barrier isn’t getting to a clinic, maybe there is that but it’s also finding cash today for diagnostics, surgery, medications, or preventive care. This is where BNPL-style health financing models could change the game: Small, structured payments instead of catastrophic out-of-pocket costs Flexible credit for essential care Reduced financial shock for chronic and long-term conditions Opportunity for digital health and fintech collaboration A pathway toward more equitable access BNPL isn’t the final solution but as Dr. Abayomi emphasized, innovative financing models are not just real engine of sustainable health systems but is a tool that is multifaceted. It is a means to an end This was really good I learnt a lot. I have always wondered If we can finance phones and fashion in installments, why not lifesaving care? But I now understand the barriers and opportunities just from this conversation The future of health financing will not be linear. It will be blended, tech-enabled, patient-centric, and creatively designed to meet people where they are. Link in first comment for the full episode on the HSB Podcast. #HSBGlobal #HealthFinancing #HealthcareInnovation #FinancialInclusion #BNPL #FintechHealth #UHC #HealthEquity #GlobalHealth #HealthSystems

💡 The latest McKinsey outlook on U.S. #healthcare (2026 and beyond) paints a challenging picture that every healthcare #startup should be watching. As between the challenges, lay great opportunities. While #payers and #providers continue to face margin pressure, the report surfaces several important signals that can help startups sharpen their go‑to‑market strategy. • Health Services & Technology (HST) is the fastest-growing segment If you’re building AI-driven #workflow automation, data connectivity, or tech-enabled services, the wind is at your back. Payers and providers are expanding their outsourcing and digital tools to manage cost pressures. Be clear with the value proposition like Humata Health and RAAPID INC. • GenAI adoption is rapidly accelerating With 85% of healthcare organizations already piloting or implementing genAI, buyers are looking for solutions that deliver immediate ROI. Startups need to lead with value clarity, not just #innovation. Master the art of converting pilot projects into production wins like ADVANCE®AI, helping pharma companies refine their GTM strategies. • Care is shifting aggressively to lower-cost settings Ambulatory surgery centers, urgent care, home health, and hospice are all expanding. GTM strategies that align to these sites of care will have a leg up, like Strolll, who offers neuro-rehab using #AR in a variety of settings. • Rising #pharmacy spend creates whitespace Specialty drugs, GLP-1s, and new pricing models are driving demand for transparency, affordability, and simpler distribution. There’s room for disruption in patient engagement, specialty logistics, and value-based pricing infrastructure. Innovators like PAXAFE and CueZen excel in cold-chain tracking and patient engagement for chronic conditions and wellness, respectively. 🚀 Startups, here's the bottom line: Lean into tech-enabled efficiency in all aspects of your business, align your value proposition with customer needs and trends, and build partnerships the generate value for the ecosystem. Microsoft for Startups Microsoft for Healthcare Jeremy Friese, MD Michael Clark Christine Duborg Jorgen Ellis Ilya Preston Ankur Teredesai Karla P. Vikas Arora Tom Pauly Carolyn Deng #StartupSuccess #AIinHealthcare #HealthcareOnLinkedIn #Pegasus #MicrosoftForStartups